Currently out of the existing stock ratings of Wangzhi Li, 12 are a BUY (80%), 3 are a HOLD (20%).

Wangzhi Li

Work Performance Price Targets & Ratings Chart

Analyst Wangzhi Li works with a stock forecast success ratio of 65% fulfilled within 186.4 days on average. Previously, Wangzhi Li worked at LADENBURG.

Wangzhi Li’s has documented 32 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on BGNE, BeiGene Ltd at 08-Dec-2020.

Wall Street Analyst Wangzhi Li

Analyst best performing recommendations are on ARCT (ARCTURUS THERAPEUTICS HOLDINGS).
The best stock recommendation documented was for ARCT (ARCTURUS THERAPEUTICS HOLDINGS) at 3/4/2020. The price target of $28 was fulfilled within 54 days with a profit of $11.22 (66.87%) receiving and performance score of 12.38.

Average potential price target upside

BGNE BeiGene Ltd ARCT Arcturus Therapeutics Holdings BLCM Bellicum Pharmaceuticals CLLS Cellectis SA KRYS Krystal Biotech

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

345

$189.92 (122.47%)

350

1 months 1 days ago

2/5 (40%)

$165.31 (92.00%)

350

Buy

285

$129.92 (83.78%)

290

5 months 2 days ago

0/3 (0%)

$119.15 (71.84%)

Hold

212

$56.92 (36.70%)

263.3

6 months 8 days ago

1/2 (50%)

$19.16 (9.94%)

1

Buy

319

$163.92 (105.70%)

321

6 months 28 days ago

3/9 (33.33%)

$105.41 (49.35%)

126

Buy

1 years 21 days ago

1/1 (100%)

$64.01 (47.07%)

249

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Wangzhi Li?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?